Search Results - "Derman BA"

Immune effector cell-associated enterocolitis post-BCMA directed CAR T-cell therapy: insights from a multicenter case series.

Authors: Susanibar-Adaniya S Derman BA Cohen AD et al.

Source: Blood cancer journal [Blood Cancer J] 2026 Apr 28; Vol. 16 (1). Date of Electronic Publication: 2026 Apr 28.

Publication Type: Letter

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process

Meta-analysis of the prognostic efficacy of daratumumab combined with standard therapy in high-risk multiple myeloma.

Authors: Zhou, Hongmei Zhang, Min Jin, Yi et al.

Source: Hematology. Dec2025, Vol. 30 Issue 1, p1-12. 12p.

Carfilzomib, lenalidomide, and dexamethasone compared with lenalidomide treatment after autologous haematopoietic stem-cell transplantation in patients with multiple myeloma (ATLAS): primary analysis of a randomised, open-label, phase 3 trial.

Authors: Dytfeld D Wróbel T Jamroziak K et al.

Source: The Lancet. Haematology [Lancet Haematol] 2026 Apr; Vol. 13 (4), pp. e241-e253. Date of Electronic Publication: 2026 Mar 11.

Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Equivalence Trial; Comparative Study

Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE

Automated RECOMIA AI-based total metabolic tumor volume in lymphoma – a retrospective study.

Authors: Sadik, May Mörk, Johanna Lopez Urdaneta, Jesus et al.

Source: EJNMMI Research. 2/27/2026, Vol. 16 Issue 1, p1-8. 8p.

Use of UV mutational signatures to distinguish between cutaneous and pulmonary primary squamous cell carcinoma.

Authors: Ross, Jeffrey S. Pavlick, Dean Tse, Julie Y. et al.

Source: Journal of Cutaneous Pathology. Jan2026, Vol. 53 Issue 1, p101-107. 7p.

Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study.

Authors: Hansen DK Dima D Mian H et al.

Source: Blood cancer journal [Blood Cancer J] 2026 Apr 14; Vol. 16 (1). Date of Electronic Publication: 2026 Apr 14.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Minimal Residual Disease Negativity as the Primary Goal of Multiple Myeloma Therapy.

Authors: Cooperrider JH Derman BA

Source: Drugs [Drugs] 2025 Oct; Vol. 85 (10), pp. 1231-1251. Date of Electronic Publication: 2025 Sep 04.

Publication Type: Journal Article; Review

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1950 (Electronic) Linking ISSN: 00126667 NLM ISO Abbreviation: Drugs Subsets: MEDLINE

Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma.

Authors: Cooperrider JH Karaoglu DA Kubicki T et al.

Source: Leukemia [Leukemia] 2025 Sep; Vol. 39 (9), pp. 2285-2288. Date of Electronic Publication: 2025 Jul 16.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; In Process

Survival predictive nomograms for non-surgical lung squamous-cell carcinoma patients with brain metastases: a SEER-based retrospective cohort study with external validation.

Authors: Cui, Xing Jia, Yisen Qi, Zuo et al.

Source: Oncologie (De Gruyter). Jan2026, Vol. 28 Issue 1, p127-139. 13p.

CAR-T cell therapy in nephrology.

Authors: Tondolo, Francesco Gessaroli, Elisa Maritati, Federica et al.

Source: Renal Failure. Dec2025, Vol. 47 Issue 1, p1-13. 13p.

Evidence for the Monitoring of Minimal Residual Disease Dynamics to Guide Clinical Practice in Patients with Multiple Myeloma.

Authors: Gan X Li L Zhang L et al.

Source: Targeted oncology [Target Oncol] 2026 Mar; Vol. 21 (2), pp. 167-186. Date of Electronic Publication: 2026 Feb 10.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE

The inhibitory effect and targets of CRM197 on tumor growth in arsenic-transformed cells and lung cancer cells.

Authors: Zhang, Xinyu Song, Shuya Tang, Jiaqi et al.

Source: Scientific Reports. 11/17/2025, Vol. 15 Issue 1, p1-14. 14p.

Impact of piR_004530 reactivation in lung cancer: implications for recurrence and survival of lung squamous cell carcinoma patients.

Authors: He, Yangyi Acosta-Plasencia, Melissa Sánchez-Lorente, David et al.

Source: BMC Medicine. 10/7/2025, Vol. 23 Issue 1, p1-20. 20p.

International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma.

Authors: Costa LJ Banerjee R Mian H et al.

Source: Leukemia [Leukemia] 2025 Mar; Vol. 39 (3), pp. 543-554. Date of Electronic Publication: 2025 Jan 27.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Population differences in the associations between chromosomal abnormalities and overall survival of multiple myeloma.

Authors: Wang B Derman BA Sukhanova M et al.

Source: Blood neoplasia [Blood Neoplasia] 2024 Dec 26; Vol. 2 (1), pp. 100065. Date of Electronic Publication: 2024 Dec 26 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE

Long enduring response on teclistamab in a patient with myeloma relapse after allogeneic hematopoietic stem cell transplantation - a case report.

Authors: Ebner P Fauser J Hetzenauer G et al.

Source: Annals of hematology [Ann Hematol] 2026 Apr 07; Vol. 105 (5). Date of Electronic Publication: 2026 Apr 07.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

Toward a cure for multiple myeloma within a decade.

Authors: Mohty M Malard F Facon T et al.

Source: Blood cancer journal [Blood Cancer J] 2026 Mar 10; Vol. 16 (1). Date of Electronic Publication: 2026 Mar 10.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Balancing Efficacy and Safety in Multiple Myeloma Patients Receiving B cell Maturation Antigen-Directed CAR T-Cell Therapy.

Authors: Kuipers MT Migchelbrink J Kramer AM et al.

Source: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2026 Jul; Vol. 40 (4), pp. 607-621. Date of Electronic Publication: 2026 May 15.

Publication Type: Journal Article; Review

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9705305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-190X (Electronic) Linking ISSN: 11738804 NLM ISO Abbreviation: BioDrugs Subsets: MEDLINE

Multiple Myeloma: Improved Outcomes Resulting from a Rapidly Expanding Number of Therapeutic Options.

Authors: Mettias S ElSayed A Moore J et al.

Source: Targeted oncology [Target Oncol] 2025 Mar; Vol. 20 (2), pp. 247-267. Date of Electronic Publication: 2025 Jan 29.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE

MRD contamination in peripheral blood autologous stem cell grafts: implications for relapse and prognosis in multiple myeloma.

Authors: Lin, Jintao He, Jingsong Cai, Zhen et al.

Source: Leukemia & Lymphoma. Feb2026, Vol. 67 Issue 3, p527-535. 9p.